Human tolerogenic DC-10: perspectives for clinical applications, Transplantation Research, vol.1, 2012. ,
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis. Annals of the Rheumatic Diseases Epub ahead of print, 2016. ,
Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients, Science Translational Medicine, vol.7, 2015. ,
Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond, Cancer Immunology Immunotherapy, vol.530, p.281, 2011. ,
It's time to bring dendritic cell therapy to type 1 diabetes, Diabetes, vol.63, 2014. ,
Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients, Diabetes Care, vol.34, 2011. ,
Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?, Clinical and Experimental Immunology, vol.172, pp.148-157, 2013. ,
Human regulatory macrophages as a cell-based medicinal product. Current Opinion in, Organ Transplantation, vol.17, pp.48-54, 2012. ,
Why most published research findings are false, PLoS Medicine, vol.2, 2005. ,
MIATA''-minimal information about T cell assays, Immunity, vol.31, pp.527-528, 2009. ,
Intraperitoneal administration of autologous tolerogenic dendritic cells for refractory Crohn's disease: a phase I study, Journal of Crohn's and Colitiss, vol.9, pp.1071-1078, 2015. ,
, MIAME guidelines. Reproductive Toxicology, vol.19, 2005.
Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells, Current Opinion in Organ Transplantation, vol.19, pp.348-356, 2014. ,